Efficacy of home-based lymphoedema management in reducing acute attacks in subjects with lymphatic filariasis in Burkina Faso
Identifieur interne : 000139 ( PascalFrancis/Corpus ); précédent : 000138; suivant : 000140Efficacy of home-based lymphoedema management in reducing acute attacks in subjects with lymphatic filariasis in Burkina Faso
Auteurs : Patrick Jullien ; Jeanne D'Arc Some ; Pierre Brantus ; Roland W. Bougma ; Issouf Bamba ; Dominique KyelemSource :
- Acta tropica [ 0001-706X ] ; 2011.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
One of the two main goals of the Global Programme to Eliminate Lymphatic Filariasis (LF) is to provide care for those suffering from the devastating clinical manifestations of this filarial infection. Among the 120 million infected people worldwide, up to 16 million have lymphoedema. The WHO strategy for managing lymphoedema is based on rigorous skin hygiene, exercise, antibiotics and antifungals when indicated. The aim is to reduce acute attacks of adenolymphangitis and cellulitis responsible for lymphoedema progression and disability. The objective of our study was to assess the effectiveness of home-based lymphoedema management implemented by the national health system of Burkina Faso. Any patient was eligible to participate in the study if suffering from LF-related lymphoedema of a lower limb at any stage, and receiving care as part of the health education and washing project between April 2005 and December 2007. The primary readout was the occurrence of an acute attack in the month preceding the consultation reported by the patient or observed by the care-giver. In all, 1089 patients were enrolled in the study. Before lymphoedema management intervention, 78.1% (95%CI: 75.5-80.5) of the patients had an acute attack in the month preceding the consultation; after four and half months of lymphoedema management, this was reduced to 39.1 % (95%CI: 36.2-42.1 ). A reduction of acute attacks related to the number of consultations or related to the patients' age and gender was not observed. Our results suggest that the home-based lymphoedema management programme in the primary health care system of Burkina Faso is effective in reducing morbidity due to LF in the short-term (4.5 months). The lymphoedema management requires no additional human resources, but whether its effect can be sustained remains to be seen.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
|
|---|
Format Inist (serveur)
| NO : | PASCAL 11-0504543 INIST |
|---|---|
| ET : | Efficacy of home-based lymphoedema management in reducing acute attacks in subjects with lymphatic filariasis in Burkina Faso |
| AU : | JULLIEN (Patrick); SOME (Jeanne D'arc); BRANTUS (Pierre); BOUGMA (Roland W.); BAMBA (Issouf); KYELEM (Dominique); KYELEM (Dominique); FISCHER (Peter U.) |
| AF : | Handicap International, 14 Avenue Berthelot/69007 Lyon/France (1 aut.); Handicap International, 13 - 41 Quartier SOCOGIM, BP 541/CP 01 Ouagadougou/Burkina Faso (2 aut.); World Health Organization/Geneva/Suisse (3 aut.); National Programme to Eliminate Lymphatic Filariasis, Ministry of Health, 03 B.P. 7009/Ouagadougou/Burkina Faso (4 aut., 5 aut., 6 aut.); Lymphatic Filariasis Support Center, Task Force for Global Health/Decatur, GA 30030/Etats-Unis (1 aut., 2 aut.); Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine/St. Louis, MO 63110/Etats-Unis (1 aut., 2 aut.); Bernhard Nocht Institute for Tropical Medicine/Hamburg/Allemagne (1 aut., 2 aut.) |
| DT : | Publication en série; Niveau analytique |
| SO : | Acta tropica; ISSN 0001-706X; Coden ACTRAQ; Royaume-Uni; Da. 2011; Vol. 120; No. SUP1; S55-S61; Bibl. 3/4 p. |
| LA : | Anglais |
| EA : | One of the two main goals of the Global Programme to Eliminate Lymphatic Filariasis (LF) is to provide care for those suffering from the devastating clinical manifestations of this filarial infection. Among the 120 million infected people worldwide, up to 16 million have lymphoedema. The WHO strategy for managing lymphoedema is based on rigorous skin hygiene, exercise, antibiotics and antifungals when indicated. The aim is to reduce acute attacks of adenolymphangitis and cellulitis responsible for lymphoedema progression and disability. The objective of our study was to assess the effectiveness of home-based lymphoedema management implemented by the national health system of Burkina Faso. Any patient was eligible to participate in the study if suffering from LF-related lymphoedema of a lower limb at any stage, and receiving care as part of the health education and washing project between April 2005 and December 2007. The primary readout was the occurrence of an acute attack in the month preceding the consultation reported by the patient or observed by the care-giver. In all, 1089 patients were enrolled in the study. Before lymphoedema management intervention, 78.1% (95%CI: 75.5-80.5) of the patients had an acute attack in the month preceding the consultation; after four and half months of lymphoedema management, this was reduced to 39.1 % (95%CI: 36.2-42.1 ). A reduction of acute attacks related to the number of consultations or related to the patients' age and gender was not observed. Our results suggest that the home-based lymphoedema management programme in the primary health care system of Burkina Faso is effective in reducing morbidity due to LF in the short-term (4.5 months). The lymphoedema management requires no additional human resources, but whether its effect can be sustained remains to be seen. |
| CC : | 002B01; 002B12B04; 002B05E03B4D |
| FD : | Lymphoedème; Filariose lymphatique; Conduite à tenir; Traitement; Aigu; Homme; Burkina; Médecine tropicale |
| FG : | Nématodose; Helminthiase; Parasitose; Infection; Afrique; Pathologie de l'appareil circulatoire; Pathologie des vaisseaux lymphatiques |
| ED : | Lymphedema; Lymphatic filariasis; Clinical management; Treatment; Acute; Human; Burkina Faso; Tropical medicine |
| EG : | Nematode disease; Helminthiasis; Parasitosis; Infection; Africa; Cardiovascular disease; Lymphatic vessel disease |
| SD : | Linfedema; Filariasis linfática; Actitud médica; Tratamiento; Agudo; Hombre; Burkina Faso; Medicina tropical |
| LO : | INIST-3165.354000507271720080 |
| ID : | 11-0504543 |
Links to Exploration step
Pascal:11-0504543Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Efficacy of home-based lymphoedema management in reducing acute attacks in subjects with lymphatic filariasis in Burkina Faso</title><author><name sortKey="Jullien, Patrick" sort="Jullien, Patrick" uniqKey="Jullien P" first="Patrick" last="Jullien">Patrick Jullien</name><affiliation><inist:fA14 i1="01"><s1>Handicap International, 14 Avenue Berthelot</s1><s2>69007 Lyon</s2><s3>FRA</s3><sZ>1 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Some, Jeanne D Arc" sort="Some, Jeanne D Arc" uniqKey="Some J" first="Jeanne D'Arc" last="Some">Jeanne D'Arc Some</name><affiliation><inist:fA14 i1="02"><s1>Handicap International, 13 - 41 Quartier SOCOGIM, BP 541</s1><s2>CP 01 Ouagadougou</s2><s3>BFA</s3><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Brantus, Pierre" sort="Brantus, Pierre" uniqKey="Brantus P" first="Pierre" last="Brantus">Pierre Brantus</name><affiliation><inist:fA14 i1="03"><s1>World Health Organization</s1><s2>Geneva</s2><s3>CHE</s3><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Bougma, Roland W" sort="Bougma, Roland W" uniqKey="Bougma R" first="Roland W." last="Bougma">Roland W. Bougma</name><affiliation><inist:fA14 i1="04"><s1>National Programme to Eliminate Lymphatic Filariasis, Ministry of Health, 03 B.P. 7009</s1><s2>Ouagadougou</s2><s3>BFA</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Bamba, Issouf" sort="Bamba, Issouf" uniqKey="Bamba I" first="Issouf" last="Bamba">Issouf Bamba</name><affiliation><inist:fA14 i1="04"><s1>National Programme to Eliminate Lymphatic Filariasis, Ministry of Health, 03 B.P. 7009</s1><s2>Ouagadougou</s2><s3>BFA</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Kyelem, Dominique" sort="Kyelem, Dominique" uniqKey="Kyelem D" first="Dominique" last="Kyelem">Dominique Kyelem</name><affiliation><inist:fA14 i1="04"><s1>National Programme to Eliminate Lymphatic Filariasis, Ministry of Health, 03 B.P. 7009</s1><s2>Ouagadougou</s2><s3>BFA</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">11-0504543</idno><date when="2011">2011</date><idno type="stanalyst">PASCAL 11-0504543 INIST</idno><idno type="RBID">Pascal:11-0504543</idno><idno type="wicri:Area/PascalFrancis/Corpus">000139</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Efficacy of home-based lymphoedema management in reducing acute attacks in subjects with lymphatic filariasis in Burkina Faso</title><author><name sortKey="Jullien, Patrick" sort="Jullien, Patrick" uniqKey="Jullien P" first="Patrick" last="Jullien">Patrick Jullien</name><affiliation><inist:fA14 i1="01"><s1>Handicap International, 14 Avenue Berthelot</s1><s2>69007 Lyon</s2><s3>FRA</s3><sZ>1 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Some, Jeanne D Arc" sort="Some, Jeanne D Arc" uniqKey="Some J" first="Jeanne D'Arc" last="Some">Jeanne D'Arc Some</name><affiliation><inist:fA14 i1="02"><s1>Handicap International, 13 - 41 Quartier SOCOGIM, BP 541</s1><s2>CP 01 Ouagadougou</s2><s3>BFA</s3><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Brantus, Pierre" sort="Brantus, Pierre" uniqKey="Brantus P" first="Pierre" last="Brantus">Pierre Brantus</name><affiliation><inist:fA14 i1="03"><s1>World Health Organization</s1><s2>Geneva</s2><s3>CHE</s3><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Bougma, Roland W" sort="Bougma, Roland W" uniqKey="Bougma R" first="Roland W." last="Bougma">Roland W. Bougma</name><affiliation><inist:fA14 i1="04"><s1>National Programme to Eliminate Lymphatic Filariasis, Ministry of Health, 03 B.P. 7009</s1><s2>Ouagadougou</s2><s3>BFA</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Bamba, Issouf" sort="Bamba, Issouf" uniqKey="Bamba I" first="Issouf" last="Bamba">Issouf Bamba</name><affiliation><inist:fA14 i1="04"><s1>National Programme to Eliminate Lymphatic Filariasis, Ministry of Health, 03 B.P. 7009</s1><s2>Ouagadougou</s2><s3>BFA</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Kyelem, Dominique" sort="Kyelem, Dominique" uniqKey="Kyelem D" first="Dominique" last="Kyelem">Dominique Kyelem</name><affiliation><inist:fA14 i1="04"><s1>National Programme to Eliminate Lymphatic Filariasis, Ministry of Health, 03 B.P. 7009</s1><s2>Ouagadougou</s2><s3>BFA</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14></affiliation></author></analytic><series><title level="j" type="main">Acta tropica</title><title level="j" type="abbreviated">Acta trop.</title><idno type="ISSN">0001-706X</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Acta tropica</title><title level="j" type="abbreviated">Acta trop.</title><idno type="ISSN">0001-706X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute</term><term>Burkina Faso</term><term>Clinical management</term><term>Human</term><term>Lymphatic filariasis</term><term>Lymphedema</term><term>Treatment</term><term>Tropical medicine</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Lymphoedème</term><term>Filariose lymphatique</term><term>Conduite à tenir</term><term>Traitement</term><term>Aigu</term><term>Homme</term><term>Burkina</term><term>Médecine tropicale</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">One of the two main goals of the Global Programme to Eliminate Lymphatic Filariasis (LF) is to provide care for those suffering from the devastating clinical manifestations of this filarial infection. Among the 120 million infected people worldwide, up to 16 million have lymphoedema. The WHO strategy for managing lymphoedema is based on rigorous skin hygiene, exercise, antibiotics and antifungals when indicated. The aim is to reduce acute attacks of adenolymphangitis and cellulitis responsible for lymphoedema progression and disability. The objective of our study was to assess the effectiveness of home-based lymphoedema management implemented by the national health system of Burkina Faso. Any patient was eligible to participate in the study if suffering from LF-related lymphoedema of a lower limb at any stage, and receiving care as part of the health education and washing project between April 2005 and December 2007. The primary readout was the occurrence of an acute attack in the month preceding the consultation reported by the patient or observed by the care-giver. In all, 1089 patients were enrolled in the study. Before lymphoedema management intervention, 78.1% (95%CI: 75.5-80.5) of the patients had an acute attack in the month preceding the consultation; after four and half months of lymphoedema management, this was reduced to 39.1 % (95%CI: 36.2-42.1 ). A reduction of acute attacks related to the number of consultations or related to the patients' age and gender was not observed. Our results suggest that the home-based lymphoedema management programme in the primary health care system of Burkina Faso is effective in reducing morbidity due to LF in the short-term (4.5 months). The lymphoedema management requires no additional human resources, but whether its effect can be sustained remains to be seen.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0001-706X</s0></fA01><fA02 i1="01"><s0>ACTRAQ</s0></fA02><fA03 i2="1"><s0>Acta trop.</s0></fA03><fA05><s2>120</s2></fA05><fA06><s3>SUP1</s3></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Efficacy of home-based lymphoedema management in reducing acute attacks in subjects with lymphatic filariasis in Burkina Faso</s1></fA08><fA09 i1="01" i2="1" l="ENG"><s1>The Diagnostics and Control of Neglected Tropical Helminth Diseases</s1></fA09><fA11 i1="01" i2="1"><s1>JULLIEN (Patrick)</s1></fA11><fA11 i1="02" i2="1"><s1>SOME (Jeanne D'arc)</s1></fA11><fA11 i1="03" i2="1"><s1>BRANTUS (Pierre)</s1></fA11><fA11 i1="04" i2="1"><s1>BOUGMA (Roland W.)</s1></fA11><fA11 i1="05" i2="1"><s1>BAMBA (Issouf)</s1></fA11><fA11 i1="06" i2="1"><s1>KYELEM (Dominique)</s1></fA11><fA12 i1="01" i2="1"><s1>KYELEM (Dominique)</s1><s9>ed.</s9></fA12><fA12 i1="02" i2="1"><s1>FISCHER (Peter U.)</s1><s9>ed.</s9></fA12><fA14 i1="01"><s1>Handicap International, 14 Avenue Berthelot</s1><s2>69007 Lyon</s2><s3>FRA</s3><sZ>1 aut.</sZ></fA14><fA14 i1="02"><s1>Handicap International, 13 - 41 Quartier SOCOGIM, BP 541</s1><s2>CP 01 Ouagadougou</s2><s3>BFA</s3><sZ>2 aut.</sZ></fA14><fA14 i1="03"><s1>World Health Organization</s1><s2>Geneva</s2><s3>CHE</s3><sZ>3 aut.</sZ></fA14><fA14 i1="04"><s1>National Programme to Eliminate Lymphatic Filariasis, Ministry of Health, 03 B.P. 7009</s1><s2>Ouagadougou</s2><s3>BFA</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></fA14><fA15 i1="01"><s1>Lymphatic Filariasis Support Center, Task Force for Global Health</s1><s2>Decatur, GA 30030</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></fA15><fA15 i1="02"><s1>Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine</s1><s2>St. Louis, MO 63110</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></fA15><fA15 i1="03"><s1>Bernhard Nocht Institute for Tropical Medicine</s1><s2>Hamburg</s2><s3>DEU</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></fA15><fA20><s2>S55-S61</s2></fA20><fA21><s1>2011</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>3165</s2><s5>354000507271720080</s5></fA43><fA44><s0>0000</s0><s1>© 2011 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>3/4 p.</s0></fA45><fA47 i1="01" i2="1"><s0>11-0504543</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Acta tropica</s0></fA64><fA66 i1="01"><s0>GBR</s0></fA66><fC01 i1="01" l="ENG"><s0>One of the two main goals of the Global Programme to Eliminate Lymphatic Filariasis (LF) is to provide care for those suffering from the devastating clinical manifestations of this filarial infection. Among the 120 million infected people worldwide, up to 16 million have lymphoedema. The WHO strategy for managing lymphoedema is based on rigorous skin hygiene, exercise, antibiotics and antifungals when indicated. The aim is to reduce acute attacks of adenolymphangitis and cellulitis responsible for lymphoedema progression and disability. The objective of our study was to assess the effectiveness of home-based lymphoedema management implemented by the national health system of Burkina Faso. Any patient was eligible to participate in the study if suffering from LF-related lymphoedema of a lower limb at any stage, and receiving care as part of the health education and washing project between April 2005 and December 2007. The primary readout was the occurrence of an acute attack in the month preceding the consultation reported by the patient or observed by the care-giver. In all, 1089 patients were enrolled in the study. Before lymphoedema management intervention, 78.1% (95%CI: 75.5-80.5) of the patients had an acute attack in the month preceding the consultation; after four and half months of lymphoedema management, this was reduced to 39.1 % (95%CI: 36.2-42.1 ). A reduction of acute attacks related to the number of consultations or related to the patients' age and gender was not observed. Our results suggest that the home-based lymphoedema management programme in the primary health care system of Burkina Faso is effective in reducing morbidity due to LF in the short-term (4.5 months). The lymphoedema management requires no additional human resources, but whether its effect can be sustained remains to be seen.</s0></fC01><fC02 i1="01" i2="X"><s0>002B01</s0></fC02><fC02 i1="02" i2="X"><s0>002B12B04</s0></fC02><fC02 i1="03" i2="X"><s0>002B05E03B4D</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Lymphoedème</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Lymphedema</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Linfedema</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Filariose lymphatique</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Lymphatic filariasis</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Filariasis linfática</s0><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Conduite à tenir</s0><s5>07</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Clinical management</s0><s5>07</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Actitud médica</s0><s5>07</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Traitement</s0><s5>08</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Treatment</s0><s5>08</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Tratamiento</s0><s5>08</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Aigu</s0><s5>09</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Acute</s0><s5>09</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Agudo</s0><s5>09</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Homme</s0><s5>10</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Human</s0><s5>10</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Hombre</s0><s5>10</s5></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Burkina</s0><s2>NG</s2><s5>13</s5></fC03><fC03 i1="07" i2="X" l="ENG"><s0>Burkina Faso</s0><s2>NG</s2><s5>13</s5></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Burkina Faso</s0><s2>NG</s2><s5>13</s5></fC03><fC03 i1="08" i2="X" l="FRE"><s0>Médecine tropicale</s0><s5>14</s5></fC03><fC03 i1="08" i2="X" l="ENG"><s0>Tropical medicine</s0><s5>14</s5></fC03><fC03 i1="08" i2="X" l="SPA"><s0>Medicina tropical</s0><s5>14</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Nématodose</s0></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Nematode disease</s0></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Nematodosis</s0></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Helminthiase</s0></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Helminthiasis</s0></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Helmintiasis</s0></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Parasitose</s0></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Parasitosis</s0></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Parasitosis</s0></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Infection</s0></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Infection</s0></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Infección</s0></fC07><fC07 i1="05" i2="X" l="FRE"><s0>Afrique</s0><s2>NG</s2></fC07><fC07 i1="05" i2="X" l="ENG"><s0>Africa</s0><s2>NG</s2></fC07><fC07 i1="05" i2="X" l="SPA"><s0>Africa</s0><s2>NG</s2></fC07><fC07 i1="06" i2="X" l="FRE"><s0>Pathologie de l'appareil circulatoire</s0><s5>37</s5></fC07><fC07 i1="06" i2="X" l="ENG"><s0>Cardiovascular disease</s0><s5>37</s5></fC07><fC07 i1="06" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0><s5>37</s5></fC07><fC07 i1="07" i2="X" l="FRE"><s0>Pathologie des vaisseaux lymphatiques</s0><s5>38</s5></fC07><fC07 i1="07" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0><s5>38</s5></fC07><fC07 i1="07" i2="X" l="SPA"><s0>Linfático patología</s0><s5>38</s5></fC07><fN21><s1>346</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard><server><NO>PASCAL 11-0504543 INIST</NO><ET>Efficacy of home-based lymphoedema management in reducing acute attacks in subjects with lymphatic filariasis in Burkina Faso</ET><AU>JULLIEN (Patrick); SOME (Jeanne D'arc); BRANTUS (Pierre); BOUGMA (Roland W.); BAMBA (Issouf); KYELEM (Dominique); KYELEM (Dominique); FISCHER (Peter U.)</AU><AF>Handicap International, 14 Avenue Berthelot/69007 Lyon/France (1 aut.); Handicap International, 13 - 41 Quartier SOCOGIM, BP 541/CP 01 Ouagadougou/Burkina Faso (2 aut.); World Health Organization/Geneva/Suisse (3 aut.); National Programme to Eliminate Lymphatic Filariasis, Ministry of Health, 03 B.P. 7009/Ouagadougou/Burkina Faso (4 aut., 5 aut., 6 aut.); Lymphatic Filariasis Support Center, Task Force for Global Health/Decatur, GA 30030/Etats-Unis (1 aut., 2 aut.); Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine/St. Louis, MO 63110/Etats-Unis (1 aut., 2 aut.); Bernhard Nocht Institute for Tropical Medicine/Hamburg/Allemagne (1 aut., 2 aut.)</AF><DT>Publication en série; Niveau analytique</DT><SO>Acta tropica; ISSN 0001-706X; Coden ACTRAQ; Royaume-Uni; Da. 2011; Vol. 120; No. SUP1; S55-S61; Bibl. 3/4 p.</SO><LA>Anglais</LA><EA>One of the two main goals of the Global Programme to Eliminate Lymphatic Filariasis (LF) is to provide care for those suffering from the devastating clinical manifestations of this filarial infection. Among the 120 million infected people worldwide, up to 16 million have lymphoedema. The WHO strategy for managing lymphoedema is based on rigorous skin hygiene, exercise, antibiotics and antifungals when indicated. The aim is to reduce acute attacks of adenolymphangitis and cellulitis responsible for lymphoedema progression and disability. The objective of our study was to assess the effectiveness of home-based lymphoedema management implemented by the national health system of Burkina Faso. Any patient was eligible to participate in the study if suffering from LF-related lymphoedema of a lower limb at any stage, and receiving care as part of the health education and washing project between April 2005 and December 2007. The primary readout was the occurrence of an acute attack in the month preceding the consultation reported by the patient or observed by the care-giver. In all, 1089 patients were enrolled in the study. Before lymphoedema management intervention, 78.1% (95%CI: 75.5-80.5) of the patients had an acute attack in the month preceding the consultation; after four and half months of lymphoedema management, this was reduced to 39.1 % (95%CI: 36.2-42.1 ). A reduction of acute attacks related to the number of consultations or related to the patients' age and gender was not observed. Our results suggest that the home-based lymphoedema management programme in the primary health care system of Burkina Faso is effective in reducing morbidity due to LF in the short-term (4.5 months). The lymphoedema management requires no additional human resources, but whether its effect can be sustained remains to be seen.</EA><CC>002B01; 002B12B04; 002B05E03B4D</CC><FD>Lymphoedème; Filariose lymphatique; Conduite à tenir; Traitement; Aigu; Homme; Burkina; Médecine tropicale</FD><FG>Nématodose; Helminthiase; Parasitose; Infection; Afrique; Pathologie de l'appareil circulatoire; Pathologie des vaisseaux lymphatiques</FG><ED>Lymphedema; Lymphatic filariasis; Clinical management; Treatment; Acute; Human; Burkina Faso; Tropical medicine</ED><EG>Nematode disease; Helminthiasis; Parasitosis; Infection; Africa; Cardiovascular disease; Lymphatic vessel disease</EG><SD>Linfedema; Filariasis linfática; Actitud médica; Tratamiento; Agudo; Hombre; Burkina Faso; Medicina tropical</SD><LO>INIST-3165.354000507271720080</LO><ID>11-0504543</ID></server></inist></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000139 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000139 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:11-0504543
|texte= Efficacy of home-based lymphoedema management in reducing acute attacks in subjects with lymphatic filariasis in Burkina Faso
}}
| This area was generated with Dilib version V0.6.31. |  |